Post: Current studies and recent publications- Lida Chatzi, MD, PhD

Current studies:
Hepatotoxic effects of perfluoroalkyl substances: a new epidemiological approach for studying environmental fatty liver disease
R01ES030691: May 1, 2020 – April 30, 2023
Role: Principal Investigator

Effects of DDE exposure on adipose tissue function, weight loss and metabolic improvement after bariatric surgery: A new paradigm for study of lipophilic chemicals
R01ES030364: February 1, 2020 – November 30, 2024
Role: Principal Investigator

Environmental Chemical Exposures and Longitudinal Changes of Glucose Metabolism, Insulin Sensitivity and B Cell Function in Youth
R01ES029944: August 15, 2019 – May 31, 2024
Role: Principal Investigator

Recent publications (2021):
Goodrich JA, Alderete TL, Baumert BO, et al. Exposure to Perfluoroalkyl Substances and Glucose Homeostasis in Youth. Environ Health Perspect. 2021;129(9):97002. doi:10.1289/EHP9200. View in PubMed- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409228/

Stratakis N, Golden-Mason L, Margetaki K, et al. In Utero Exposure to Mercury Is Associated With Increased Susceptibility to Liver Injury and Inflammation in Childhood. Hepatology. 2021;74(3):1546-1559. doi:10.1002/hep.31809. View in PubMed- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446089/

Share:

More Posts

David Armstrong, PhD, DPM was featured on MedScape

On June 24, Medscape featured commentary by David Armstrong, PhD, DPM, podiatric surgeon with Keck Medicine and professor of surgery and neurological surgery, on treating infected diabetic foot ulcers. Click

Everyday Health quoted Alyssa Dominguez, MD

On June 25, Everyday Health quoted Alyssa Dominguez, MD, endocrinologist with Keck Medicine and clinical assistant professor of medicine (clinician educator), on a study associating semaglutide use with reduced risk of